# The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)

> **NCT02107222** · NA · WITHDRAWN · sponsor: **Maquet Cardiopulmonary GmbH**

## Conditions studied

- COPD
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DEVICE:** CO2-Removal (PALP-Device/MaquetCP)

## Key facts

- **NCT ID:** NCT02107222
- **Lead sponsor:** Maquet Cardiopulmonary GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This action is an internal decision that was not made because of any pending regulatory action for these products.
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02107222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02107222, "The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02107222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*